Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC-Reference-Cited by-同舟云学术

Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC

Author:

Lin Hongyan¹,Ai Dongxuan¹,Liu Qingqing¹,Wang Xinling¹,Gao Jiale¹,Chen Qingqing²,Ruan Lingyu¹,Tao Yuheng¹,Gao Jian³,Wang Liqun¹^ORCID

Affiliation:

1. School of Pharmacy, Changzhou University, Changzhou 213164, China

2. State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China

3. School of Medicine, Anhui University of Science and Technology, Huainan 232002, Anhui, China

Funder

National Key Research and Development Program of China

Changzhou Science and Technology Bureau

Changzhou University

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

Reference36 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献